Literature DB >> 25524268

Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.

Ranajoy Majumdar1, Reza Esfandiary, Steven M Bishop, Hardeep S Samra, C Russell Middaugh, David B Volkin, David D Weis.   

Abstract

This study compares the local conformational dynamics and physical stability of an IgG1 mAb (mAb-A) with its corresponding YTE (M255Y/S257T/T259E) mutant (mAb-E), which was engineered for extended half-life in vivo. Structural dynamics was measured using hydrogen/deuterium (H/D) exchange mass spectrometry while protein stability was measured with differential scanning calorimetry (DSC) and size exclusion chromatography (SEC). The YTE mutation induced differences in H/D exchange kinetics at both pH 6.0 and 7.4. Segments covering the YTE mutation sites and the FcRn binding epitopes showed either subtle or no observable differences in local flexibility. Surprisingly, several adjacent segments in the CH2 and distant segments in the VH, CH1, and VL domains had significantly increased flexibility in the YTE mutant. Most notable among the observed differences is increased flexibility of the 244-254 segment of the CH2 domain, where increased flexibility has been shown previously to correlate with decreased conformational stability and increased aggregation propensity in other IgG1 mAbs (e.g., presence of destabilizing additives as well as upon de-glycosylation or methionine oxidation). DSC analysis showed decreases in both thermal onset (Tonset) and unfolding (Tm1) temperatures of 7°C and 6.7°C, respectively, for the CH2 domain of the YTE mutant. In addition, mAb-E aggregated faster than mAb-A under accelerated stability conditions as measured by SEC analysis. Hence, the relatively lower physical stability of the YTE mutant correlates with increased local flexibility of the 244-254 segment, providing a site-directed mutant example that this segment of the CH2 domain is an aggregation hot spot in IgG1 mAbs.

Entities:  

Keywords:  CH1-CH3, constant domains 1–3, respectively, of the heavy chain of a monoclonal antibody; DSC, differential scanning calorimetry; Fab, antigen binding fragment of a monoclonal antibody; Fc, crystallizable fragment of a monoclonal antibody; HC, heavy chain of a monoclonal antibody; HX-MS, hydrogen/deuterium exchange mass spectrometry; LC, light chain of a monoclonal antibody; VH/VL, variable domain of the heavy/light chain of a monoclonal antibody; YTE mutation; aggregation; differential scanning calorimetry; flexibility; hydrogen/deuterium exchange; immunoglobulin G1; mass spectrometry; monoclonal antibody; stability

Mesh:

Substances:

Year:  2015        PMID: 25524268      PMCID: PMC4623389          DOI: 10.4161/19420862.2014.985494

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  66 in total

1.  Identification of critical IgG binding epitopes on the neonatal Fc receptor.

Authors:  D E Vaughn; C M Milburn; D M Penny; W L Martin; J L Johnson; P J Bjorkman
Journal:  J Mol Biol       Date:  1997-12-12       Impact factor: 5.469

Review 2.  Fc receptors and their interactions with immunoglobulins.

Authors:  M Raghavan; P J Bjorkman
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

3.  Structural insights into neonatal Fc receptor-based recycling mechanisms.

Authors:  Vaheh Oganesyan; Melissa M Damschroder; Kimberly E Cook; Qing Li; Changshou Gao; Herren Wu; William F Dall'Acqua
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

4.  Effects of salts from the Hofmeister series on the conformational stability, aggregation propensity, and local flexibility of an IgG1 monoclonal antibody.

Authors:  Ranajoy Majumdar; Prakash Manikwar; John M Hickey; Hardeep S Samra; Hasige A Sathish; Steven M Bishop; C Russell Middaugh; David B Volkin; David D Weis
Journal:  Biochemistry       Date:  2013-05-02       Impact factor: 3.162

5.  Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry.

Authors:  Lucy Yan Pan; Oscar Salas-Solano; John F Valliere-Douglass
Journal:  Anal Chem       Date:  2014-02-21       Impact factor: 6.986

6.  Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.

Authors:  Céline Monnet; Sylvie Jorieux; Nathalie Souyris; Ouafa Zaki; Alexandra Jacquet; Nathalie Fournier; Fabien Crozet; Christophe de Romeuf; Khalil Bouayadi; Rémi Urbain; Christian K Behrens; Philippe Mondon; Alexandre Fontayne
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

7.  Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling.

Authors:  Aming Zhang; Ping Hu; Paul MacGregor; Yu Xue; Haihong Fan; Peter Suchecki; Leonard Olszewski; Aston Liu
Journal:  Anal Chem       Date:  2014-03-14       Impact factor: 6.986

8.  A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults.

Authors:  Gabriel J Robbie; Ryan Criste; William F Dall'acqua; Kathryn Jensen; Nita K Patel; Genevieve A Losonsky; M Pamela Griffin
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

9.  Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements.

Authors:  Roxana E Iacob; George M Bou-Assaf; Lee Makowski; John R Engen; Steven A Berkowitz; Damian Houde
Journal:  J Pharm Sci       Date:  2013-10-17       Impact factor: 3.534

10.  Understanding the relationship between biotherapeutic protein stability and solid-liquid interfacial shear in constant region mutants of IgG1 and IgG4.

Authors:  Roumteen Tavakoli-Keshe; Jonathan J Phillips; Richard Turner; Daniel G Bracewell
Journal:  J Pharm Sci       Date:  2013-12-19       Impact factor: 3.534

View more
  26 in total

1.  Conformational Plasticity of the Immunoglobulin Fc Domain in Solution.

Authors:  Soumya G Remesh; Anthony A Armstrong; Andrew D Mahan; Jinquan Luo; Michal Hammel
Journal:  Structure       Date:  2018-05-03       Impact factor: 5.006

2.  Spin Diffusion Editing for Structural Fingerprints of Therapeutic Antibodies.

Authors:  Joshua Franks; John N Glushka; Michael T Jones; David H Live; Qin Zou; James H Prestegard
Journal:  Anal Chem       Date:  2015-12-22       Impact factor: 6.986

Review 3.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

4.  Localized conformational interrogation of antibody and antibody-drug conjugates by site-specific carboxyl group footprinting.

Authors:  Lucy Yan Pan; Oscar Salas-Solano; John F Valliere-Douglass
Journal:  MAbs       Date:  2016-12-08       Impact factor: 5.857

5.  Hydrogen/deuterium exchange mass spectrometry and computational modeling reveal a discontinuous epitope of an antibody/TL1A Interaction.

Authors:  Richard Y-C Huang; Stanley R Krystek; Nathan Felix; Robert F Graziano; Mohan Srinivasan; Achal Pashine; Guodong Chen
Journal:  MAbs       Date:  2017-11-14       Impact factor: 5.857

6.  Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.

Authors:  Surinder M Singh; Swati Bandi; David N M Jones; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2017-08-24       Impact factor: 3.534

7.  Modification of the kinetic stability of immunoglobulin G by solvent additives.

Authors:  Jonas V Schaefer; Erik Sedlák; Florian Kast; Michal Nemergut; Andreas Plückthun
Journal:  MAbs       Date:  2018-04-25       Impact factor: 5.857

8.  Analysis of IgG kinetic stability by differential scanning calorimetry, probe fluorescence and light scattering.

Authors:  Michal Nemergut; Gabriel Žoldák; Jonas V Schaefer; Florian Kast; Pavol Miškovský; Andreas Plückthun; Erik Sedlák
Journal:  Protein Sci       Date:  2017-09-06       Impact factor: 6.725

9.  Interlaboratory Comparison of Hydrogen-Deuterium Exchange Mass Spectrometry Measurements of the Fab Fragment of NISTmAb.

Authors:  Jeffrey W Hudgens; Elyssia S Gallagher; Ioannis Karageorgos; Kyle W Anderson; James J Filliben; Richard Y-C Huang; Guodong Chen; George M Bou-Assaf; Alfonso Espada; Michael J Chalmers; Eduardo Harguindey; Hui-Min Zhang; Benjamin T Walters; Jennifer Zhang; John Venable; Caitlin Steckler; Inhee Park; Ansgar Brock; Xiaojun Lu; Ratnesh Pandey; Arun Chandramohan; Ganesh Srinivasan Anand; Sasidhar N Nirudodhi; Justin B Sperry; Jason C Rouse; James A Carroll; Kasper D Rand; Ulrike Leurs; David D Weis; Mohammed A Al-Naqshabandi; Tyler S Hageman; Daniel Deredge; Patrick L Wintrode; Malvina Papanastasiou; John D Lambris; Sheng Li; Sarah Urata
Journal:  Anal Chem       Date:  2019-05-14       Impact factor: 6.986

10.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.